Skip to NavigationSkip to content

News

MSD is trialling an implant that prevents patients from contracting HIV, The Guardian has said.
Takeda has unveiled new Phase 3 data for a subcutaneous formulation of its gut-selective biologic Entyvio, showing that the therapy met its primary...
Drug resistant malaria parasites are spreading rapidly in South East Asia, according to researchers from Thailand and the United Kingdom.
The US regulator awarded marketing approval to generic products from Teva, Dr Reddy’s Laboratories, Alembic Pharmaceuticals, Alkem Laboratories,...
Acadia Pharmaceuticals’ has said its schizophrenia drug Nuplazid (primavanserin) has failed to beat placebo in a Phase 3 trial.
Gilead has acquired the rights to three of Novartis’ preclinical antiviral programmes, including investigational compounds with the potential to...
Biohaven Pharmaceutical has seen its new therapy formulation for the treatment of amyotrophic lateral sclerosis (ALS) rejected by the FDA, it has...
Britain’s cost-effectiveness body NICE has said it will review the methods it uses to develop guidance on drugs, medical devices, and diagnostics.
Celgene has revealed the US approval of Otezla for the treatment of with oral ulcers in adult patients with the rare and chronic inflammatory...
The Department of Health and Social Care (DHSC) paid £9.2 billion to private providers in the year prior to 31 March 2019, according to their annual...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches